News
Hosted on MSN1mon
Study identifies novel pathway with potential to slow the progression of pulmonary fibrosisIdiopathic pulmonary fibrosis (IPF) is a devastating progressive ... The American Journal of Pathology (2025). DOI: 10.1016/j.ajpath.2024.12.015 ...
1mon
GlobalData on MSNQureight and Remedy Cell to validate RC-0315 in Phase Ib trial for IPFExploratory objectives include assessing its impact on the pathology of the disease ... by the progressive interstitial lung disease, IPF. The disease is characterised by thickening and stiffening ...
CDC researchers report a rate of 7.1 per 100,000, an increase from 5.3 per 100,000 in a previous study. But improved ...
An already approved cancer drug, Yervoy (ipilimumab), improved lung repair ability in a study of mice with idiopathic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results